Showing results (1-10 of 141) with videos related to
Sort By:
Pageof 15
The Journal of Clinical Investigation|June 15, 2022
Finding the right help in the tumor microenvironmentJessica N Filderman, Walter J StorkusClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2020
Neoepitopes as Difference Makers for General Cancer Vaccines?Jessica N Filderman, Walter J StorkusCancers|June 2, 2021
STING Agonists as Cancer TherapeuticsAfsaneh Amouzegar, Manoj Chelvanambi, Jessica N Filderman, et al.Frontiers in Immunology|May 31, 2021
STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure DevelopmentJessica N Filderman, Mark Appleman, Manoj Chelvanambi, et al.Expert Opinion on Biological Therapy|January 9, 2003
Dendritic cell-based vaccines and therapies for cancerTomohide Tatsumi, Walter J StorkusFrontiers in Oncology|August 15, 2022
Editorial: Immunotherapy in renal cell carcinomaViktor Gruenwald, Walter J StorkusFrontiers in Immunology|February 5, 2024
Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonistsJessica N Filderman, Jennifer L Taylor, Jianmin Wang, et al.Advances in Experimental Medicine and Biology|December 25, 2017
Immunotherapeutic Targeting of Tumor-Associated Blood VesselsKellsye L Fabian, Walter J StorkusVaccines|July 27, 2024
Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1Jennifer L Taylor, Kathleen M Kokolus, Per H Basse, et al.Advances in Cancer Research|July 29, 2015
Therapeutic Lymphoid Organogenesis in the Tumor MicroenvironmentAliyah M Weinstein, Walter J StorkusPageof 15